January 26, 2015 2:23 PM ET


Company Overview of AusAm Biotechnologies, Inc.

Company Overview

AusAm Biotechnologies, Inc. operates as a biotechnology research and development company. The company focuses on commercializing diagnostic and therapeutic products to identify and treat various diseases. It offers Accumin, an assay for the detection of intact albumin in urine, as well as for use in the diagnosis and treatment of disease conditions, such as renal or heart diseases, or thyroid disorders. AusAm Biotechnologies offers its products through reference laboratories and hospitals in the United States. The company was incorporated in 2000 and is based in New York, New York. On February 7, 2006, AusAm Biotechnologies, Inc. filed a voluntary petition for reorganization under Chapter 11...

645 Madison Avenue

Suite 502

New York, NY 10022

United States

Founded in 2000





Key Executives for AusAm Biotechnologies, Inc.

President and Director
Chief Financial Officer
Chief Operating Officer
Director of Clinical Trials and Director
Senior Research Coordinator
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
BioCarta LLC United States
Avicena Group, Inc. United States
ReproCELL USA Inc. United States
Miltenyi Biotec Inc. United States
Argonaut Technologies Systems, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AusAm Biotechnologies, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.